Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion type Assertion NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_head.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion description "[The risk for colorectal cancer did not appear to differ significantly amongst individuals featuring the XRCC1 399Arg/Arg genotype (OR = 1.18; 95% CI, 0.96-1.45), the XRCC3 241Thr/Thr genotype (OR = 1.25; 95% CI, 0.88-1.79) or the XPD 751Gln allele (OR = 1.20; 95% CI, 0.90-1.61), although individuals featuring a greater number of risk genotypes (genotype with OR greater than 1) did experience a higher risk for colorectal cancer when compared to those who didn't feature any risk genotypes (Trend test P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_provenance.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion evidence source_evidence_literature NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_provenance.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion SIO_000772 15679883 NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_provenance.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion wasDerivedFrom gad-20130706 NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_provenance.
- NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_assertion wasGeneratedBy ECO_0000203 NP59385.RAj5KwZ6yrz9x6Fe8t1Fffb68FYXCD2ZlExTX3GZK0Ie8130_provenance.